Behandlingens virkning blev hovedsagelig bedømt på ændringen i niveauet af et stof i blodet, som kaldes glykosyleret hæmoglobin (HbA1c), som indikerer, hvor godt blodglukoseniveauet reguleres.
The main measure of effectiveness was the change in the blood levels of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well blood glucose is controlled.